Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the

Daichi Shimbo1, Jonathan D Newman, Joseph E Schwartz

  • 1Department of Medicine, Columbia University Medical Center, New York, New York, USA. ds2231@columbia.edu

Insights

Masked hypertension and prehypertension significantly overlap and are linked to increased cardiovascular risk. Ambulatory blood pressure monitoring may not be necessary for individuals with optimal clinic blood pressure.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Clinical Diagnostics

Background:

  • Masked hypertension (MHT) and prehypertension (PHT) increase cardiovascular disease (CVD) risk compared to normotension.
  • Understanding the overlap between MHT and PHT is crucial for assessing CVD risk.
  • Left ventricular mass index (LVMI) is a key indicator of cardiovascular end-organ damage.

Purpose of the Study:

  • To investigate the diagnostic overlap between masked hypertension and prehypertension.
  • To examine the relationship between MHT, PHT, and left ventricular mass index (LVMI).

Main Methods:

  • 813 participants without treated hypertension underwent clinic blood pressure (CBP) and 24-hour ambulatory blood pressure (ABP) monitoring.
  • Left ventricular mass index (LVMI) was assessed via echocardiography in 784 participants.
  • Data analysis adjusted for multiple cardiovascular risk factors.

Main Results:

  • A significant overlap was observed: 83.8% of MHT participants also had PHT, and 34.1% of PHT participants had MHT.
  • MHT was rare (3.9%) in individuals with optimal CBP (<120/80 mm Hg).
  • Elevated LVMI was associated with both PHT without MHT and PHT with MHT, compared to optimal CBP with MHT.

Conclusions:

  • Substantial diagnostic overlap exists between masked hypertension and prehypertension in a community sample.
  • Ambulatory blood pressure monitoring may not be clinically indicated for individuals with optimal clinic blood pressure readings.
  • Further research is needed to refine diagnostic strategies for hypertension subtypes.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.